 | • レポートコード：MRC23Q38381 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の直腸膣瘻治療市場について調査・分析し、世界の直腸膣瘻治療市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（上部直腸腟瘻、下部直腸腟瘻）、用途別セグメント分析（病院、外来手術センター）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Cook Medical、Takeda Pharmaceutical Company、Johnson & Johnson Services Inc.、Pfizer Inc.、Allergan、AbbVie Inc、Novartis International AG、Bayer AG、Bristol-Myers Squibb、Boehringer Ingelheim GmbHなどが含まれています。世界の直腸膣瘻治療市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、直腸膣瘻治療市場規模を推定する際に考慮しました。本レポートは、直腸膣瘻治療の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、直腸膣瘻治療に関するビジネス上の意思決定に役立てることを目的としています。 ・直腸膣瘻治療市場の概要 - 製品の定義 - 直腸膣瘻治療のタイプ別セグメント - 世界の直腸膣瘻治療市場規模：タイプ別分析（上部直腸腟瘻、下部直腸腟瘻） - 直腸膣瘻治療の用途別セグメント - 世界の直腸膣瘻治療市場規模：用途別分析（病院、外来手術センター） - 世界の直腸膣瘻治療市場規模予測（2018年-2029年） - 直腸膣瘻治療の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 直腸膣瘻治療市場の競争状況およびトレンド ・直腸膣瘻治療の地域別市場規模 - 北米の直腸膣瘻治療市場規模（2018年-2029年） - アメリカの直腸膣瘻治療市場規模（2018年-2029年） - ヨーロッパの直腸膣瘻治療市場規模（2018年-2029年） - アジア太平洋の直腸膣瘻治療市場規模（2018年-2029年） - 中国の直腸膣瘻治療市場規模（2018年-2029年） - 日本の直腸膣瘻治療市場規模（2018年-2029年） - 韓国の直腸膣瘻治療市場規模（2018年-2029年） - インドの直腸膣瘻治療市場規模（2018年-2029年） - オーストラリアの直腸膣瘻治療市場規模（2018年-2029年） - 中南米の直腸膣瘻治療市場規模（2018年-2029年） - 中東・アフリカの直腸膣瘻治療市場規模（2018年-2029年） ・タイプ別セグメント：上部直腸腟瘻、下部直腸腟瘻 - 世界の直腸膣瘻治療のタイプ別販売量（2018年-2023年） - 世界の直腸膣瘻治療のタイプ別売上（2018年-2023年） - 世界の直腸膣瘻治療のタイプ別価格 ・用途別セグメント：病院、外来手術センター - 世界の直腸膣瘻治療の用途別販売量（2018年-2023年） - 世界の直腸膣瘻治療の用途別売上（2018年-2023年） - 世界の直腸膣瘻治療の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Cook Medical、Takeda Pharmaceutical Company、Johnson & Johnson Services Inc.、Pfizer Inc.、Allergan、AbbVie Inc、Novartis International AG、Bayer AG、Bristol-Myers Squibb、Boehringer Ingelheim GmbH ・産業チェーンと販売チャネルの分析 - 直腸膣瘻治療産業チェーン分析 - 直腸膣瘻治療の主要原材料 - 直腸膣瘻治療の販売チャネル - 直腸膣瘻治療のディストリビューター - 直腸膣瘻治療の主要顧客 ・直腸膣瘻治療市場ダイナミクス - 直腸膣瘻治療の業界動向 - 直腸膣瘻治療市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Rectovaginal Fistula Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Rectovaginal Fistula Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Rectovaginal Fistula Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Rectovaginal Fistula Treatment include Cook Medical, Takeda Pharmaceutical Company, Johnson & Johnson Services Inc., Pfizer Inc., Allergan, AbbVie Inc, Novartis International AG, Bayer AG and Bristol-Myers Squibb, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Rectovaginal Fistula Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rectovaginal Fistula Treatment.
The Rectovaginal Fistula Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Rectovaginal Fistula Treatment market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rectovaginal Fistula Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Cook Medical
Takeda Pharmaceutical Company
Johnson & Johnson Services Inc.
Pfizer Inc.
Allergan
AbbVie Inc
Novartis International AG
Bayer AG
Bristol-Myers Squibb
Boehringer Ingelheim GmbH
Segment by Type
High Rectovaginal Fistula
Low Rectovaginal Fistula
Segment by Application
Hospital
Ambulatory Surgery Center
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Rectovaginal Fistula Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Rectovaginal Fistula Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Rectovaginal Fistula Treatment Market Overview
1.1 Product Overview and Scope of Rectovaginal Fistula Treatment
1.2 Rectovaginal Fistula Treatment Segment by Type
1.2.1 Global Rectovaginal Fistula Treatment Market Value Comparison by Type (2023-2029)
1.2.2 High Rectovaginal Fistula
1.2.3 Low Rectovaginal Fistula
1.3 Rectovaginal Fistula Treatment Segment by Application
1.3.1 Global Rectovaginal Fistula Treatment Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Ambulatory Surgery Center
1.4 Global Rectovaginal Fistula Treatment Market Size Estimates and Forecasts
1.4.1 Global Rectovaginal Fistula Treatment Revenue 2018-2029
1.4.2 Global Rectovaginal Fistula Treatment Sales 2018-2029
1.4.3 Global Rectovaginal Fistula Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Rectovaginal Fistula Treatment Market Competition by Manufacturers
2.1 Global Rectovaginal Fistula Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Rectovaginal Fistula Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Rectovaginal Fistula Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Rectovaginal Fistula Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Rectovaginal Fistula Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rectovaginal Fistula Treatment, Product Type & Application
2.7 Rectovaginal Fistula Treatment Market Competitive Situation and Trends
2.7.1 Rectovaginal Fistula Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rectovaginal Fistula Treatment Players Market Share by Revenue
2.7.3 Global Rectovaginal Fistula Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Rectovaginal Fistula Treatment Retrospective Market Scenario by Region
3.1 Global Rectovaginal Fistula Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Rectovaginal Fistula Treatment Global Rectovaginal Fistula Treatment Sales by Region: 2018-2029
3.2.1 Global Rectovaginal Fistula Treatment Sales by Region: 2018-2023
3.2.2 Global Rectovaginal Fistula Treatment Sales by Region: 2024-2029
3.3 Global Rectovaginal Fistula Treatment Global Rectovaginal Fistula Treatment Revenue by Region: 2018-2029
3.3.1 Global Rectovaginal Fistula Treatment Revenue by Region: 2018-2023
3.3.2 Global Rectovaginal Fistula Treatment Revenue by Region: 2024-2029
3.4 North America Rectovaginal Fistula Treatment Market Facts & Figures by Country
3.4.1 North America Rectovaginal Fistula Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Rectovaginal Fistula Treatment Sales by Country (2018-2029)
3.4.3 North America Rectovaginal Fistula Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rectovaginal Fistula Treatment Market Facts & Figures by Country
3.5.1 Europe Rectovaginal Fistula Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Rectovaginal Fistula Treatment Sales by Country (2018-2029)
3.5.3 Europe Rectovaginal Fistula Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rectovaginal Fistula Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Rectovaginal Fistula Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Rectovaginal Fistula Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Rectovaginal Fistula Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rectovaginal Fistula Treatment Market Facts & Figures by Country
3.7.1 Latin America Rectovaginal Fistula Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Rectovaginal Fistula Treatment Sales by Country (2018-2029)
3.7.3 Latin America Rectovaginal Fistula Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rectovaginal Fistula Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Rectovaginal Fistula Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Rectovaginal Fistula Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Rectovaginal Fistula Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Rectovaginal Fistula Treatment Sales by Type (2018-2029)
4.1.1 Global Rectovaginal Fistula Treatment Sales by Type (2018-2023)
4.1.2 Global Rectovaginal Fistula Treatment Sales by Type (2024-2029)
4.1.3 Global Rectovaginal Fistula Treatment Sales Market Share by Type (2018-2029)
4.2 Global Rectovaginal Fistula Treatment Revenue by Type (2018-2029)
4.2.1 Global Rectovaginal Fistula Treatment Revenue by Type (2018-2023)
4.2.2 Global Rectovaginal Fistula Treatment Revenue by Type (2024-2029)
4.2.3 Global Rectovaginal Fistula Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Rectovaginal Fistula Treatment Price by Type (2018-2029)
5 Segment by Application
5.1 Global Rectovaginal Fistula Treatment Sales by Application (2018-2029)
5.1.1 Global Rectovaginal Fistula Treatment Sales by Application (2018-2023)
5.1.2 Global Rectovaginal Fistula Treatment Sales by Application (2024-2029)
5.1.3 Global Rectovaginal Fistula Treatment Sales Market Share by Application (2018-2029)
5.2 Global Rectovaginal Fistula Treatment Revenue by Application (2018-2029)
5.2.1 Global Rectovaginal Fistula Treatment Revenue by Application (2018-2023)
5.2.2 Global Rectovaginal Fistula Treatment Revenue by Application (2024-2029)
5.2.3 Global Rectovaginal Fistula Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Rectovaginal Fistula Treatment Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Cook Medical
6.1.1 Cook Medical Corporation Information
6.1.2 Cook Medical Description and Business Overview
6.1.3 Cook Medical Rectovaginal Fistula Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Cook Medical Rectovaginal Fistula Treatment Product Portfolio
6.1.5 Cook Medical Recent Developments/Updates
6.2 Takeda Pharmaceutical Company
6.2.1 Takeda Pharmaceutical Company Corporation Information
6.2.2 Takeda Pharmaceutical Company Description and Business Overview
6.2.3 Takeda Pharmaceutical Company Rectovaginal Fistula Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Takeda Pharmaceutical Company Rectovaginal Fistula Treatment Product Portfolio
6.2.5 Takeda Pharmaceutical Company Recent Developments/Updates
6.3 Johnson & Johnson Services Inc.
6.3.1 Johnson & Johnson Services Inc. Corporation Information
6.3.2 Johnson & Johnson Services Inc. Description and Business Overview
6.3.3 Johnson & Johnson Services Inc. Rectovaginal Fistula Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Johnson & Johnson Services Inc. Rectovaginal Fistula Treatment Product Portfolio
6.3.5 Johnson & Johnson Services Inc. Recent Developments/Updates
6.4 Pfizer Inc.
6.4.1 Pfizer Inc. Corporation Information
6.4.2 Pfizer Inc. Description and Business Overview
6.4.3 Pfizer Inc. Rectovaginal Fistula Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Inc. Rectovaginal Fistula Treatment Product Portfolio
6.4.5 Pfizer Inc. Recent Developments/Updates
6.5 Allergan
6.5.1 Allergan Corporation Information
6.5.2 Allergan Description and Business Overview
6.5.3 Allergan Rectovaginal Fistula Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Allergan Rectovaginal Fistula Treatment Product Portfolio
6.5.5 Allergan Recent Developments/Updates
6.6 AbbVie Inc
6.6.1 AbbVie Inc Corporation Information
6.6.2 AbbVie Inc Description and Business Overview
6.6.3 AbbVie Inc Rectovaginal Fistula Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 AbbVie Inc Rectovaginal Fistula Treatment Product Portfolio
6.6.5 AbbVie Inc Recent Developments/Updates
6.7 Novartis International AG
6.6.1 Novartis International AG Corporation Information
6.6.2 Novartis International AG Description and Business Overview
6.6.3 Novartis International AG Rectovaginal Fistula Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis International AG Rectovaginal Fistula Treatment Product Portfolio
6.7.5 Novartis International AG Recent Developments/Updates
6.8 Bayer AG
6.8.1 Bayer AG Corporation Information
6.8.2 Bayer AG Description and Business Overview
6.8.3 Bayer AG Rectovaginal Fistula Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bayer AG Rectovaginal Fistula Treatment Product Portfolio
6.8.5 Bayer AG Recent Developments/Updates
6.9 Bristol-Myers Squibb
6.9.1 Bristol-Myers Squibb Corporation Information
6.9.2 Bristol-Myers Squibb Description and Business Overview
6.9.3 Bristol-Myers Squibb Rectovaginal Fistula Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Bristol-Myers Squibb Rectovaginal Fistula Treatment Product Portfolio
6.9.5 Bristol-Myers Squibb Recent Developments/Updates
6.10 Boehringer Ingelheim GmbH
6.10.1 Boehringer Ingelheim GmbH Corporation Information
6.10.2 Boehringer Ingelheim GmbH Description and Business Overview
6.10.3 Boehringer Ingelheim GmbH Rectovaginal Fistula Treatment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Boehringer Ingelheim GmbH Rectovaginal Fistula Treatment Product Portfolio
6.10.5 Boehringer Ingelheim GmbH Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rectovaginal Fistula Treatment Industry Chain Analysis
7.2 Rectovaginal Fistula Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rectovaginal Fistula Treatment Production Mode & Process
7.4 Rectovaginal Fistula Treatment Sales and Marketing
7.4.1 Rectovaginal Fistula Treatment Sales Channels
7.4.2 Rectovaginal Fistula Treatment Distributors
7.5 Rectovaginal Fistula Treatment Customers
8 Rectovaginal Fistula Treatment Market Dynamics
8.1 Rectovaginal Fistula Treatment Industry Trends
8.2 Rectovaginal Fistula Treatment Market Drivers
8.3 Rectovaginal Fistula Treatment Market Challenges
8.4 Rectovaginal Fistula Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer